MedTrace Logo

Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients

NCT04181190 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2020-11-04

No results posted yet for this study

Summary

Real-life, observational, retrospective, multicenter study to evaluate the effects of anti-IL5 biological treatments on blood total IgE Levels in atopic patients with severe eosinophilic asthma.

Conditions

Interventions

DIAGNOSTIC_TEST

Total IgE

Levels of total IgE before biological treatments and at 4±2 months of treatments

DIAGNOSTIC_TEST

Blood cell counts

White Blood Cell Count and Differential (and in particular the levels of total leucocytes, lymphocytes, eosinophils and basophils)

DIAGNOSTIC_TEST

Asthma control assessment

Levels of asthma control assessed by asthma control questionnaire (ACT) before initiation of biological treatments and at 4± months of treatments

DIAGNOSTIC_TEST

lung function tests

Lung function tests performed before initiation of biological treatments and at 4± months of treatments

Sponsors & Collaborators

  • Università degli Studi di Ferrara

    lead OTHER

Principal Investigators

  • Marco Contoli, Prof · Università di Ferrara - Azienda Ospedaliero Universitaria di Ferrara

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-11
Primary Completion
2020-10-01
Completion
2020-11-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04181190 on ClinicalTrials.gov